pSivida Cash and Equivalents
pSivida Cash and Equivalents Chart
View Cash and Equivalents for PSDV.
Start Your YCharts Pro Platinum Membership.
pSivida Historical Cash and Equivalents Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| June 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
About Cash and Equivalents
Cash and equivalents is cash or cash equivalents that a company possesses at any given time. Examples of cash equivalents are: money market accounts, treasury bills, and short term government bonds. Cash and cash equivalents are a business' most liquid assets. Cash on hand results from a positive cash flow statement.
Investors look at cash on hand as a reflection of a company's solvency and liquidity.
Learn More
View Cash and Equivalents for PSDV.
Start Your YCharts Pro Platinum Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $199/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Platinum Member? Sign in here.
PSDV Cash and Equivalents Benchmarks
| Companies | |
|---|---|
| Alimera Sciences | Go Pro |
| Acura Pharmaceuticals | Go Pro |
| Sagent Pharmaceuticals | Go Pro |
PSDV Cash and Equivalents Rankings
| Overall |
51st percentile 3872 of 8002 |
| Sector |
37th percentile 430 of 684 in Healthcare |
| Industry |
29th percentile 48 of 68 in Drug Manufacturers - Specialty & Generic |
PSDV Cash and Equivalents Range, Past 5 Years
| Minimum | Go Pro | Mar 2010 |
| Maximum | Go Pro | Jun 2008 |
| Average | Go Pro |